Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/Fine Chemicals Roundup – November 29
6:30 AM MST | November 29, 2011 | Deepti Ramesh
JOHNSON MATTHEY REPORTS RISE IN PROFITS By Natasha Alperowicz Johnson Matthey, in the first half ended September 30, 2011, reported a 23% increase in underlying operating profit to £214.7 million ($335.7 million) on 29% higher sales, including precious metals, at £5.98 billion. Sales excluding precious metals were 17% up at £1.3 billion with “good growth across all of the group’s divisions.” Johnson Matthey fine chemicals division reported a 13% rise in underlying operating profit to £32.5 million on 15% higher revenue of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee